The BB1 monoclonal antibody recognizes both cell surface CD74 (MHC class II-associated invariant chain) as well as B7-1 (CD80), resolving the question regarding a third CD28/CTLA-4 counterreceptor

Journal of Immunology

Volumn 161, Issue 6, 1998, Pages 2708-2715

  Freeman, Gordon J ^a   Cardoso, Angelo A ^a   Boussiotis, Vassiliki A ^a   Anumanthan, Anukanth ^a   Groves, Richard W ^b   Kupper, Thomas S ^b   Clark, Edward A ^c   Nadler, Lee M ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; LYMPHOCYTE ANTIGEN; MONOCLONAL ANTIBODY;

ANTIGEN ANTIBODY REACTION; ANTIGEN RECOGNITION; ARTICLE; LYMPHOCYTE ACTIVATION; MOLECULAR CLONING; PRIORITY JOURNAL;

3T3 CELLS; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, BLOCKING; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD80; ANTIGENS, DIFFERENTIATION; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; BINDING SITES, ANTIBODY; CHO CELLS; CLONING, MOLECULAR; COS CELLS; CRICETINAE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNOCONJUGATES; IMMUNOGLOBULIN FC FRAGMENTS; INTERFERON TYPE II; KERATINOCYTES; LEUKEMIA, PRE-B-CELL; MICE; MOLECULAR SEQUENCE DATA; PHENOTYPE; RECOMBINANT FUSION PROTEINS; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0032530275     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Boussiotis, V. A., G. J. Freeman, J. G. Gribben, and L. M. Nadler. 1996. The role of B7-1/B7-2:CD28/CTLA-4 pathways in the prevention of anergy, induction of productive immunity and down-regulation of the immune response. Immunol. Rev. 153:1.
2. Linsley, P. S., E. A. Clark, and J. A. Ledbetter. 1990. T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. Proc. Natl. Acad. Sci. USA 87:5031.
3. Freedman, A. S., G. J. Freeman, J. C. Horowitz, J. Daley, and L. M. Nadler. 1987. B7, a B cell restricted antigen which identifies pre-activated B cells. J. Immunol. 137:3260.
4. Yokochi, T., R. D. Holly, and E. A. Clark. 1982. Lymphoblastoid antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid lines, and Burkitt's lymphomas. J. Immunol. 128:823.
5. Boussiotis, V. A., G. J. Freeman, J. G. Gribben, J. Daley, G. Gray, and L. M. Nadler. 1993. Activated human B lymphocytes express three CTLA-4 binding counter-receptors which costimulate T cell activation. Proc. Natl. Acad. Sci. USA 90:11059.
6. Freeman, G. J., J. G. Gribben, V. A. Boussiotis, J. W. Ng, V. Restivo, L. Lombard, G. S. Gray, and L. M. Nadler. 1993. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 262:909.
7. Azuma, M., D. Ito, H. Yagita, K. Okumura, J. H. Phillips, L. L. Lanier, and C. Somoza. 1993. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366:76.
8. Engel, P., N. Wagner, and T. Tedder. 1995. CD80 Workshop Report. In Leukocyte Typing. V. S. F. Schlossman, L. Boumsell, W. Gilks, J. M. Harlan, T. Kishimoto, C. Morimoto, J. Ritz, S. Shaw, R. Silverstein, T. Springer, T. F. Tedder, and R. F. Todd, eds. Oxford University Press, Oxford, p. 682.
9. Engel, P., J. G. Gribbben, G. J. Freeman, L. J. Zhou, Y. Nozawa, M. Abe, L. M. Nadler, H. Wakawsa, and T. F. Tedder. 1994. The B7-2 (B70) costimulatory molecule of monocytes and activated B lymphocytes is the CD86 differentiation antigen. Blood 84:1402.
10. Clark, E. A., and T. Yokochi. 1984. Human B cell and B cell blast-associated surface molecules defined with monoclonal antibodies. In Leukocyte Typing. A. Bernard, L. Boumsell, J. Dausset, C. Milstein, and S. F. Schlossman, eds. Springer-Verlag, Berlin, p.339.
11. Katz, F. E., M. Parkar, K. Stanley, L. J. Murray, E. A. Clark, and M. F. Greaves. 1985. Chromosome mapping of cell membrane antigens expressed on activated B cells. Eur. J. Immunol. 15:103.
12. Freeman, G. J., C. M. Disteche, J. G. Gribben, D. A. Adler, A. S. Freedman, J. Dougery, and L. M. Nadler. 1992. The gene for B7, a costimulatory signal for T cell activation, maps to chromosomal region 3q13. 3-3q21. Blood 79:489.
13. Nickoloff, B., R. Mitra, K. Lee, L. Turka, J. Green, G. Thompson, and Y. Shimizu. 1993. Discordant expression of CD28 ligands, BB1, and B7 on keratinocytes in vitro and psoriatic cells in vivo. Am. J. Pathol 142:1029.
14. Valle, A., P. Garrone, H. Yssel, J.-Y. Bonnefoy, A. S. Freedman, G. Freeman, L. M. Nadler, and J. Banchereau. 1990. mAb 104, a new monoclonal antibody, recognizes the B7 antigen that is expressed on activated B cells and HTLV-1-transformed T cells. Immunology 69:531.
15. Rennert, P., K. Furlong, C. Jellis, E. Greenfield, G. J. Freeman, Y. Ueda, B. Levine, C. H. June, and G. S. Gray. 1997. The IgV domain of human B7-2 (CD86) is sufficient to co-stimulate T lymphocytes and induce cytokine secretion. Int. Immunol. 9:805.
16. Linsley, P. S., W. Brady, M. Urnes, L. S. Grosmaire, N. K. Damle, and J. A. Ledbetter. 1991. CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 174:561.
17. Freeman, G. J., V. A. Boussiotis, A. Anumanthan, G. M. Bernstein, X.-Y. Ke, P. D. Rennert, G. S. Gray, J. G. Gribben, and L. M. Nadler. 1995. B7-1 and B7-2 do not deliver identical costimulatory signals since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 2:523.
18. Mizushima, S., and S. Nagata. 1990. pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res. 18:5322.
19. Kay, R., and R. K. Humphries. 1991. New vectors and procedures for isolating cDNAs encoding cell surface proteins by expression cloning in COS cells. Methods Mol Cell. Biol. 2:254.
20. Seed, B., and A. Arrufo. 1987. Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure. Proc. Natl. Acad. Sci. USA 84:3365.
21. Freeman, G. J., A. S. Freedman, J. M. Segil, G. Lee, J. F. Whitman, and L. M. Nadler. 1989. B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J. Immunol. 143:2714.
22. Freeman, G. J., D. B. Lombard, C. D. Gimmi, S. A. Brod, K. Lee, J. C. Laning, D. A. Hafler, M. E. Dorf, G. Gray, H. Reiser, C. H. June, C. B. Thompson, and L. M. Nadler. 1992. CTLA-4 and CD28 mRNAs are coexpressed in most activated T cells after activation: expression of CTLA-4 and CD28 messenger RNA does not correlate with the pattern of lymphokine production. J. Immunol. 149: 3795.
23. Cardoso, A. A., J. A. Schultze, V. A. Boussiotis, G. J. Freeman, M. J. Seamon, S. Laszlo, A. Billet, S. Sallan, J. G. Gribben, and L. M. Nadler. 1996. Pre-B acute lymphoblastic leukemia cells may induce T-cell anergy to alloantigen. Blood 88:41.
24. Schultze, J. S., A. A. Cardoso, G. J. Freeman, M. J. Seamon, J. Daley, G. S. Pinkus, J. G. Gribben, and L. M. Nadler. 1995. Follicular lymphomas can be induced to present alloantigen efficiently: a conceptual model to improve their tumor immunogenicity. Proc. Natl. Acad. Sci. USA 92:8200.
25. Strubin, M., B. Mach, and E. O. Long. 1984. The complete sequence of the mRNA for the HLA-DR-associated invariant chain reveals a polypeptide with an unusual transmembrane polarity. EMBO J. 3:869.
26. Koch, N., G. Moldenhauer, W. J. Hofmann, and P. Moller. 1991. Rapid intracellular pathway gives rise to cell surface expression of the MHC class II-associated invariant chain (CD74). J. Immunol 147:2643.
27. Moller, P., C. Henne, and G. Moldenhauer. 1995. CD74 Workshop panel report. In Leukocyte Typing. V. S. F. Schlossman, L. Boumsell, W. Gilks, J. M. Harlan, T. Kishimoto, C. Morimoto, J. Ritz, S. Shaw, R. Silverstein, T. Springer, T. F. Tedder, and R. F. Todd, eds. Oxford University Press. Oxford, p.568.
28. Wraight, C. J., P. van Enden, P. Moller, J. Lipp, N. R. Ling, I. C. M. MacLennan, N. Koch, and G. Moldenhauer. 1990. Human major histocompatibility complex class II invariant chain is expressed on the cell surface. J. Biol. Chem. 265:5787.
29. Freeman, G. J., J. Ng, A. Anumanthan, J. G. Gribben, V. A. Boussiotis, E. Greenfield, P. D. Rennert, G. S. Gray, and L. M. Nadler. 1994. CTLA-4 binding requires only the B7-1 Ig-V domain but costimulation requires both Ig-V and Ig-C domains. Blood 84(Suppl 1):528a(Abstr.).
30. Fargeas, C. A., A. Truneh, M. Reddy, M. Hurle, R. Sweet, and R.-P. Sekaly. 1995. Identification of residues in the V domain of CD80 (B7-1) implicated in functional interactions with CD28 and CTLA-4. J. Exp. Med. 182:667.
31. Peach, R. J., J. Bajorath, J. Naemura, G. Leytze, J. Greene, A. Aruffo, and P. S. Linsley. 1995. Both extracellular immunoglobulin-like domains of CD80 contain residues critical for binding T cell surface receptors CTLA-4 and CD28. J. Biol. Chem. 270:21181.
32. Zhang, D., and R. P. Johnson. 1997. Molecular cloning and comparative analysis of the rhesus macaque costimulatory molecules CD80 (B7-1) and CD86 (B7-2). Cell. Immunol. 177:9.
33. Augustin, M., A. Dietrich, R. Niedner, A. Kapp, E. Schopf, J. Ledbetter, W. Brandy, P. Linsley, and J. Simon. 1993. Phorbol-12-Myristate-13-Acetate-treated human keratinocytes express B7-like molecules that serve a costimulatory role in T cell activation. J. Invest. Dermatol. 100:275.
34. Clark, E. A., J. A. Ledbetter, R. C. Holly, P. A. Dinndorf, and G. Shu. 1986. Polypeptides on human B lymphocytes associated with cell activation. Hum. Immunol 16:100.
35. Turka, L. A., P. S. Linsley, R. Paine, G. L. Schieven, C. B. Thompson, and J. A. Ledbetter. 1991. Signal transduction via CD4, CD8, and CD28 in mature and immature thymocytes: implications for thymic selection. J. Immunol. 146: 1428.
36. Munro, M., A. Freedman, J. Aster, J. Gribben, N. Lee, K. Rhynhart, J. Banchereau, and L. Nadler. 1994. In vivo expression of the B7 costimulatory molecule by subsets of antigen-presenting cells and the malignant cells of Hodgkin's disease. Blood 83:793.
37. Vandenberghe, P., J. Delabie, M. de Boer, C. De Wolf-Peeters, and J. L. Ceuppens. 1993. In situ expression of B7/BB1 on antigen-presenting cells and activated B cells: an immunohistochemical study. Int. Immunol. 5:317.
38. Mach, B., V. Steimle, E. Martinez-Soria, and W. Reith. 1996. Regulation of MHC class II genes: lessons from a disease. Annu. Rev. Immunol. 14:301.
39. Brown, A. M., C. L. Barr, and J. P. Y. Ting. 1991. Sequences homologous to class II MHC W, X, and Y elements mediate constitutive and IFN-gamma-induced expression of human class II-associated invariant chain gene. J. Immunol. 146:3183.
40. Muhlethaler, A., L. A. Otten, V. Steimle, and B. Mach. 1997. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the trans-activator CIITA. EMBO J. 16:2851.
41. + T cells. J. Exp. Med. 173:759.
42. Nabavi, N., G. J. Freeman, A. Gault, D. Godfrey, L. M. Nadler, and L. H. Glimcher. 1992. Signaling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression. Nature 360:266.
43. Nickoloff, B. J., and L. A. Turka. 1994. Immunological functions of non-professional antigen-presenting cells: new insights from studies of T cell interactions with keratinocytes. Immunol Today 15:464.
44. Griffiths, C. E. M., J. Esmann, G. J. Fisher, and B. J. Nickoloff. 1990. Gamma interferon differentially modulated keratinocyte expression of HLA-DR and intercellular adhesion molecule-1 (ICAM-1): evidence for a protein kinase C-dependent and independent pathway. Br. J. Dermatol. 122:333.
45. Volc-Platzer, B., O. Majdic, W. Knapp, K. Wolff, W. Hinterberger, K. Lechner, and G. Stingl. 1984. Evidence of human HLA-DR antigen biosynthesis by human keratinocytes in disease. J. Exp. Med. 159:1784.
46. Claesson-Welsh, L., A. Scheynius, U. Tjernlund, and P. A. Peterson. 1986. Cell surface expression of invariant gamma-chain of class II histocompatibility antigens in human skin. J. Immunol. 136:484.
47. Naujokas, M. F., M. Morin, M. S. Anderson, M. Peterson, and J. Miller. 1993. The chondroitin sulfate form of invariant chain can enhance stimulation of T cell responses through interaction with CD44. Cell. 74:257.
48. Kupfer, A., and S. J. Singer. 1989. The specific interaction of helper T cells and antigen-presenting B cells. IV. Membrane and cytoskeletal reorganizations in the bound T cell as a function of antigen dose. J. Exp. Med. 170:1697.
49. Kupfer, A., T. R. Mosmann, and H. Kupfer. 1991. Polarized expression of cytokines in cell conjugates of helper T cells and splenic B cells. Proc. Natl. Acad. Sci. USA 88:775.
50. Kupfer, H., C. R. F. Monks, and A. Kupfer. 1994. Small splenic B cells that bind to antigen-specific T helper (Th) cells and face the site of cytokine production in the Th cells selectively proliferate: immunofluorescence microscopic studies of Th-B antigen-presenting cell interactions. J. Exp. Med. 179:1507.
51. Linsley, P. S., J. Bradshaw, J. Greene, R. Peach, K. L. Bennet, and R. S. Mittler. 1996. Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement. Immunity 535.
52. Cresswell, P. 1994. Assembly, transport, and function of MHC class II molecules. Annu. Rev. Immunol. 12:259.
53. Arunachalam, B., C. A. Lamb, and P. Cresswell. 1994. Transport properties of free and MHC class II-associated oligomers containing different isoforms of human invariant chain. Int. Immunol. 6:439.
54. Lamb, C. A., J. W. Yewdell, J. R. Bennink, and P. Cresswell. 1991. Invariant chain targets HLA class II molecules to acidic endosomes containing internalized influenza virus. Proc. Natl. Acad. Sci. USA 88:5998.
55. Romagnoli, P., C. Layet, J. Yewdell, O. Bakke, and R. N. Germain. 1993. Relationship between invariant chain expression and major histocompatibility complex class II transport into early and late endocytic compartments. J. Exp. Med. 177:583.
56. Henne, C., F. Schwenk, N. Koch, and P. Moller. 1995. Surface expression of the invariant chain (CD74) is independent of concomitant expression of major histocompatibility complex class II antigens. Immunology 84:177.
57. Bordello, F., M. P. Sethna, S. D. Boyd, A. N. Schweitzer, E. A. Tivol, D. Jacoby, T. B. Strom, S. E. A., G. J. Freeman, and A. H. Sharpe. 1997. B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity 6:303.
58. Lawrence, C. B., and D. A. Goldman. 1988. Definition and identification of homology domains. Comput. Appl. Biosci. 4:25.